SPY756.82−0.39%QQQ686.06−0.63%BTC/USD71,283.55−3.58%DIA523.49−0.18%GLD353.29−3.25%TLT80.27−0.80%

Immunocore Holdings PLC

IMCRNASDAQ

Trade with Public

$31.65

N/A

Last update: Nov 11, 4:00 PM

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Earnings: Q3 2026 Earnings were released on Fri Nov 6th, before the market open

Immunocore Holdings (IMCR) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Immunocore Holdings (IMCR) stock.

Analyst Consensus — 14 Analysts

11Buy

2Hold

1Sell

# Analysts14

Latest Upgrades and Downgrades for Immunocore Holdings Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	HC Wainwright & Co.	Patrick R. Trucchio	PT Cut	Buy	$100→$80
—	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$100
—	JP Morgan	Jessica Fye	Reinstates	Overweight	$50
—	Mizuho	Graig Suvannavejh	PT Raise	Neutral	$34→$35
—	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$100
—	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$100
—	Jefferies	Clara Dong	Downgrade	Buy→Hold	$48→$33
—	Needham	Gil Blum	PT Raise	Buy	$71→$75
—	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$100
—	UBS	Michael Yee	Assumes	Sell→Buy	$24→$55
—	Morgan Stanley	Andrew Galler	PT Raise	Equal-Weight	$34→$36
—	Wells Fargo	Eva Fortea Verdejo	Initiate	Overweight	$60
—	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$100
—	Guggenheim	Paul Jeng	Assumes	Neutral	—
—	HC Wainwright & Co.	Patrick Trucchio	Maintained	Buy	$100
—	Oppenheimer	Jeff Jones	PT Raise	Outperform	$85→$86
—	Barclays	Peter Lawson	PT Cut	Overweight	$66→$52
—	JP Morgan	Jessica Fye	PT Cut	Overweight	$54→$50
—	Needham	Gil Blum	Maintained	Buy	$71
—	Mizuho	Graig Suvannavejh	PT Cut	Neutral	$38→$33

Immunocore Holdings PLC

Immunocore Holdings (IMCR) Stock Price Target 2026

Latest Upgrades and Downgrades for Immunocore Holdings Stock

Immunocore Holdings (IMCR) Stock Price Target 2026

Latest Upgrades and Downgrades for Immunocore Holdings Stock

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Immunocore Holdings, Lowers Price Target to $80

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PRO
JP Morgan Reinstates Overweight on Immunocore Holdings, Announces $50 Price Target

PRO
Mizuho Maintains Neutral on Immunocore Holdings, Raises Price Target to $35

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

People Also Watch

People Also Watch

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Immunocore Holdings, Lowers Price Target to $80

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PRO
JP Morgan Reinstates Overweight on Immunocore Holdings, Announces $50 Price Target

PRO
Mizuho Maintains Neutral on Immunocore Holdings, Raises Price Target to $35

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

Immunocore Holdings PLC

Immunocore Holdings (IMCR) Stock Price Target 2026

Latest Upgrades and Downgrades for Immunocore Holdings Stock

Immunocore Holdings (IMCR) Stock Price Target 2026

Latest Upgrades and Downgrades for Immunocore Holdings Stock

Analyst Ratings News

PROHC Wainwright & Co. Maintains Buy on Immunocore Holdings, Lowers Price Target to $80

PROHC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PROJP Morgan Reinstates Overweight on Immunocore Holdings, Announces $50 Price Target

PROMizuho Maintains Neutral on Immunocore Holdings, Raises Price Target to $35

PROHC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PROHC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

People Also Watch

People Also Watch

Analyst Ratings News

PROHC Wainwright & Co. Maintains Buy on Immunocore Holdings, Lowers Price Target to $80

PROHC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PROJP Morgan Reinstates Overweight on Immunocore Holdings, Announces $50 Price Target

PROMizuho Maintains Neutral on Immunocore Holdings, Raises Price Target to $35

PROHC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PROHC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Immunocore Holdings, Lowers Price Target to $80

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PRO
JP Morgan Reinstates Overweight on Immunocore Holdings, Announces $50 Price Target

PRO
Mizuho Maintains Neutral on Immunocore Holdings, Raises Price Target to $35

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Immunocore Holdings, Lowers Price Target to $80

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PRO
JP Morgan Reinstates Overweight on Immunocore Holdings, Announces $50 Price Target

PRO
Mizuho Maintains Neutral on Immunocore Holdings, Raises Price Target to $35

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target